GLP-1 receptor agonists, including the blockbuster drugs semaglutide and tirzepatide, are increasingly being prescribed to patients with type 1 diabetes, despite having no FDA approval for this indication, according to a study published Wednesday in the Journal of the American Medical Association
WEIGHT LOSS: Carnitine works as a fat transporter, helping to move fat cells to the mitochondria where they are burned away for good
But the GLP-1 shortage ended this year, so selling copycat GLP-1s became illegal
Macher, Stefan (Department of Neurology, Medical University of Vienna)
Sermorelin has an even shorter half-life than Mod GRF 1-29, approximately 10-20 minutes
M is grateful to UGC for Junior Research Fellowship and AS, AK and ST are thankful to CSIR for senior research fellowship